Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06670040 · ClinicalTrials.gov registry record · NA

Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder and Autism, sponsored by Children's Hospital Medical Center, Cincinnati.

Active
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06670040 is a NA study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 24 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06670040, a NA study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Evaluate the efficacy of accelerated theta burst stimulation (aTBS) in reducing depressive symptoms in autism spectrum disorder (ASD)

Interventions

  • PROCEDURE Transcranial Magnetic Stimulation
  • PROCEDURE Transcranial Magnetic Stimulation Sham

Study Locations (1)

Ohio

  • Cincinnati Childrens Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-09-16
Est. Completion 2026-04-30
Phase NA

What the Registry Record Tells You About NCT06670040

The ClinicalTrials.gov registry entry for NCT06670040 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT06670040 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06670040 about?

NCT06670040 is a clinical study titled "Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder". Evaluate the efficacy of accelerated theta burst stimulation (aTBS) in reducing depressive symptoms in autism spectrum disorder (ASD)

What is the current status of trial NCT06670040?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-09-16. Estimated completion is 2026-04-30.

What conditions does trial NCT06670040 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Depression - Major Depressive Disorder, MDD, ASD.

What interventions are being tested in trial NCT06670040?

The interventions under investigation include: Transcranial Magnetic Stimulation (PROCEDURE), Transcranial Magnetic Stimulation Sham (PROCEDURE).

Who is sponsoring clinical trial NCT06670040?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06670040 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.